• レポートコード:TMR2006033 • 出版社/出版日:Transparency Market Research / 2020年3月 • レポート形態:英文、PDF、180ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、心嚢穿刺処置の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などを総合的に調査・分析して掲載しております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・心嚢穿刺処置の世界市場規模:疾患別(感染症、悪性腫瘍、炎症性/リウマチ、心臓、その他) ・心嚢穿刺処置の世界市場規模:エンドユーザー別 ・心嚢穿刺処置の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ) ・競争状況 |
Pericardiocentesis Procedures Market – Scope of the Report
TMR’s report on the global pericardiocentesis procedures market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue and volume (number of procedures) of the global pericardiocentesis procedures market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pericardiocentesis procedures market for the forecast period.
The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global pericardiocentesis procedures market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global pericardiocentesis procedures market.
The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global pericardiocentesis procedures market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global pericardiocentesis procedures market. The next section of the global pericardiocentesis procedures market report highlights the USPs, which include regulatory scenario, overview of large pericardial effusions, reimbursement scenario, and booming investments in private hospitals in India.
The report also delves into the competitive landscape of the global pericardiocentesis procedures market. Key players operating in the global pericardiocentesis procedures treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global pericardiocentesis procedures treatment market report.
Key Questions Answered in Global Pericardiocentesis Procedures Market Report
What is the sales/revenue generated by different pericardiocentesis procedures across all the regions during the forecast period?
How many pericardiocentesis procedures were performed in 2018, by region/sub-region?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Pericardiocentesis Procedures Market – Research Objectives and Approach
The comprehensive report on the global pericardiocentesis procedures market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global pericardiocentesis procedures market. It is followed by market introduction, market dynamics, and an overview of the global pericardiocentesis procedures market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the pericardiocentesis procedures market. The next section of the global pericardiocentesis procedures market report highlights the USPs, including regulatory scenario, overview of large pericardial effusions, reimbursement scenario, and booming investments in private hospitals in India.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated and number of pericardiocentesis surgeries performed by key pericardiocentesis service providers has been mapped to ascertain the size of the global pericardiocentesis procedures market in terms of value and volume. The forecast presented here assesses the total revenue generated and number of pericardiocentesis procedures. In order to provide an accurate forecast, we took into consideration the parent cardiac tamponade market.
The report analyzes the global pericardiocentesis procedures market in terms of indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the pericardiocentesis procedures market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pericardiocentesis Procedures Market
4. Market Overview
4.1. Introduction
4.1.1. Pericardiocentesis Procedures Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pericardiocentesis Procedures Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Overview of Large Pericardial Effusions
5.3. Reimbursement Scenario
5.4. Booming investments in private hospitals in India
6. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Indication, 2017–2027
6.3.1. Infections
6.3.1.1. Tuberculosis Infection
6.3.1.2. Bacterial Infection
6.3.1.3. Others
6.3.2. Malignancies
6.3.2.1. Lung Cancer
6.3.2.2. Breast Cancer
6.3.2.3. Lymphoma
6.3.2.4. Others
6.3.3. Inflammatory/Rheumatology
6.3.3.1. Rheumatoid Arthritis
6.3.3.2. Systemic Lupus Erythromatosus
6.3.3.3. Others
6.3.4. Cardiac
6.3.5. Others
6.4. Market Attractiveness Analysis, by Indication
7. Global Pericardiocentesis Procedures Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Cardiac Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Global Pericardiocentesis Procedures Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Indication, 2017–2027
9.3.1. Infections
9.3.1.1. Tuberculosis Infection
9.3.1.2. Bacterial Infection
9.3.1.3. Others
9.3.2. Malignancies
9.3.2.1. Lung Cancer
9.3.2.2. Breast Cancer
9.3.2.3. Lymphoma
9.3.2.4. Others
9.3.3. Inflammatory/Rheumatology
9.3.3.1. Rheumatoid Arthritis
9.3.3.2. Systemic Lupus Erythromatosus
9.3.3.3. Others
9.3.4. Cardiac
9.3.5. Others
9.4. Market Value Forecast, by End-user, 2017–2027
9.4.1. Hospitals
9.4.2. Cardiac Centers
9.4.3. Others
9.5. Market Value Forecast, by Country, 2017–2027
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Indication
9.6.2. By End-user
9.6.3. By Country
10. Europe Global Pericardiocentesis Procedures Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Indication, 2017–2027
10.3.1. Infections
10.3.1.1. Tuberculosis Infection
10.3.1.2. Bacterial Infection
10.3.1.3. Others
10.3.2. Malignancies
10.3.2.1. Lung Cancer
10.3.2.2. Breast Cancer
10.3.2.3. Lymphoma
10.3.2.4. Others
10.3.3. Inflammatory/Rheumatology
10.3.3.1. Rheumatoid Arthritis
10.3.3.2. Systemic Lupus Erythromatosus
10.3.3.3. Others
10.3.4. Cardiac
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Cardiac Centers
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Global Pericardiocentesis Procedures Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Indication, 2017–2027
11.3.1. Infections
11.3.1.1. Tuberculosis Infection
11.3.1.2. Bacterial Infection
11.3.1.3. Others
11.3.2. Malignancies
11.3.2.1. Lung Cancer
11.3.2.2. Breast Cancer
11.3.2.3. Lymphoma
11.3.2.4. Others
11.3.3. Inflammatory/Rheumatology
11.3.3.1. Rheumatoid Arthritis
11.3.3.2. Systemic Lupus Erythromatosus
11.3.3.3. Others
11.3.4. Cardiac
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Cardiac Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Technique
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Global Pericardiocentesis Procedures Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Indication, 2017–2027
12.3.1. Infections
12.3.1.1. Tuberculosis Infection
12.3.1.2. Bacterial Infection
12.3.1.3. Others
12.3.2. Malignancies
12.3.2.1. Lung Cancer
12.3.2.2. Breast Cancer
12.3.2.3. Lymphoma
12.3.2.4. Others
12.3.3. Inflammatory/Rheumatology
12.3.3.1. Rheumatoid Arthritis
12.3.3.2. Systemic Lupus Erythromatosus
12.3.3.3. Others
12.3.4. Cardiac
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Cardiac Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Technique
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East and Africa Global Pericardiocentesis Procedures Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Indication, 2017–2027
13.3.1. Infections
13.3.1.1. Tuberculosis Infection
13.3.1.2. Bacterial Infection
13.3.1.3. Others
13.3.2. Malignancies
13.3.2.1. Lung Cancer
13.3.2.2. Breast Cancer
13.3.2.3. Lymphoma
13.3.2.4. Others
13.3.3. Inflammatory/Rheumatology
13.3.3.1. Rheumatoid Arthritis
13.3.3.2. Systemic Lupus Erythromatosus
13.3.3.3. Others
13.3.4. Cardiac
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Cardiac Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Technique
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. New York-Presbyterian Hospital/Weill Cornell Medical Center
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Florida Hospital Orlando
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cleveland Clinic
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. John Hopkins Hospital
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Saint George Hospital
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Buddhist Tzu Chi General Hospital
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. J. W. Goethe University Hospital
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. The University of Tokyo Hospital
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Heart Institute, University of Sao Paulo
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Mediclinic International
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Apollo Hospitals Enterprise Ltd
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
List of TablesTable 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 02: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 03: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 04: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 05: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: Global Pericardiocentesis Procedures Market Volume (Number of Procedures) Forecast, by Region, 2017–2027
Table 08: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 10: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 11: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 12: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 13: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 16: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 17: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 18: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 19: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 20: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 22: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 23: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 24: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 25: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 26: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 28: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 29: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 30: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 31: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 32: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 33: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 34: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027
Table 35: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027
Table 36: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027
Table 37: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027